Literature DB >> 25787773

A Review: Phytochemicals Targeting JAK/STAT Signaling and IDO Expression in Cancer.

Niroshaathevi Arumuggam1, Neil A Bhowmick2, H P Vasantha Rupasinghe1,3.   

Abstract

Cancer remains a major health problem worldwide. Among many other factors, two regulatory defects that are present in most cancer cells are constitutive activation of Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway and the induction of indoleamine 2, 3-dioxygenase (IDO), an enzyme that catalyzes tryptophan degradation, through JAK/STAT signaling. Cytokine signaling activates STAT proteins in regulating cell proliferation, differentiation, and survival through modulation of target genes. Many phytochemicals can inhibit both JAK/STAT signaling and IDO expression in antigen-presenting cells by targeting different pathways. Some of the promising phytochemicals that are discussed in this review include resveratrol, cucurbitacin, curcumin, (-)-epigallocatechin gallate, and others. It is now evident that phytochemicals play key roles in inhibition of tumor proliferation and development and provide novel means for therapeutic targeting of cancer.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  JAK/STAT; cancer; epigenetics; indoleamine 2, 3-dioxygenase (IDO); phytochemicals

Mesh:

Substances:

Year:  2015        PMID: 25787773     DOI: 10.1002/ptr.5327

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  18 in total

1.  Phloridzin docosahexaenoate, a novel flavonoid derivative, suppresses growth and induces apoptosis in T-cell acute lymphoblastic leukemia cells.

Authors:  Niroshaathevi Arumuggam; Nicole Melong; Catherine Kl Too; Jason N Berman; Hp Vasantha Rupasinghe
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

2.  GKN2 increases apoptosis, reduces the proliferation and invasion ability of gastric cancer cells through down-regulating the JAK/STAT signaling pathway.

Authors:  Jun Ouyang; Xiaohui Pan; Hui Lin; Zecheng Hu; Ping Xiao; Haobin Hu
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

3.  Indoleamine 2,3-Dioxygenase Activity-Induced Acceleration of Tumor Growth, and Protein Kinases-Related Novel Therapeutics Regimens.

Authors:  Ayse Basak Engin; Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Aryl hydrocarbon receptor-kynurenine axis promotes oncogenic activity in BCP-ALL.

Authors:  Li-Ting Wang; Kwei-Yan Liu; Shen-Nien Wang; Ming-Hong Lin; Yu-Mei Liao; Pei-Chin Lin; Shau-Ku Huang; Shih-Hsien Hsu; Shyh-Shin Chiou
Journal:  Cell Biol Toxicol       Date:  2022-06-10       Impact factor: 6.691

5.  Stat3 is a candidate epigenetic biomarker of perinatal Bisphenol A exposure associated with murine hepatic tumors with implications for human health.

Authors:  Caren Weinhouse; Ingrid L Bergin; Craig Harris; Dana C Dolinoy
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

6.  [Chrysin inhibits lipopolysaccharide-induced inflammatory responses of macrophages via JAK-STATs signaling pathway].

Authors:  Shi-Mei Qi; Qiang Li; Qi Jiang; Zhi-Lin Qi; Yao Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-03-20

7.  Pharmacological Properties of Chromobacterium violaceum Violacein at the Human Serotonin 2C Receptor.

Authors:  Letimicia S Fears; Mary E Curtis; Terrance L Johnson; Hugh M Fentress
Journal:  EC Pharmacol Toxicol       Date:  2016-04-01

8.  Synergic Effect of α-Mangostin on the Cytotoxicity of Cisplatin in a Cervical Cancer Model.

Authors:  Jazmin M Pérez-Rojas; Raquel González-Macías; Jaime González-Cortes; Rafael Jurado; José Pedraza-Chaverri; Patricia García-López
Journal:  Oxid Med Cell Longev       Date:  2016-12-08       Impact factor: 6.543

9.  Gedunin inhibits pancreatic cancer by altering sonic hedgehog signaling pathway.

Authors:  Ramadevi Subramani; Elizabeth Gonzalez; Sushmita Bose Nandy; Arunkumar Arumugam; Fernando Camacho; Joshua Medel; Damilola Alabi; Rajkumar Lakshmanaswamy
Journal:  Oncotarget       Date:  2017-02-14

10.  Dexamethasone suppresses immune evasion by inducing GR/STAT3 mediated downregulation of PD-L1 and IDO1 pathways.

Authors:  Zhen Xiang; Zhijun Zhou; Shuzheng Song; Jun Li; Jun Ji; Ranlin Yan; Jiexuan Wang; Wei Cai; Wenjun Hu; Lu Zang; Zhenggang Zhu; Zhen Zhang; Min Li; Yingyan Yu
Journal:  Oncogene       Date:  2021-06-26       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.